204 related articles for article (PubMed ID: 21507972)
1. Blocking eIF4E-eIF4G interaction as a strategy to impair coronavirus replication.
Cencic R; Desforges M; Hall DR; Kozakov D; Du Y; Min J; Dingledine R; Fu H; Vajda S; Talbot PJ; Pelletier J
J Virol; 2011 Jul; 85(13):6381-9. PubMed ID: 21507972
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
[TBL] [Abstract][Full Text] [Related]
3. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
Walsh D
Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117
[TBL] [Abstract][Full Text] [Related]
6. Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.
Papadopoulos E; Jenni S; Kabha E; Takrouri KJ; Yi T; Salvi N; Luna RE; Gavathiotis E; Mahalingam P; Arthanari H; Rodriguez-Mias R; Yefidoff-Freedman R; Aktas BH; Chorev M; Halperin JA; Wagner G
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):E3187-95. PubMed ID: 25049413
[TBL] [Abstract][Full Text] [Related]
7. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E.
Ohlmann T; Rau M; Pain VM; Morley SJ
EMBO J; 1996 Mar; 15(6):1371-82. PubMed ID: 8635470
[TBL] [Abstract][Full Text] [Related]
8. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
[TBL] [Abstract][Full Text] [Related]
9. Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells.
Frosi Y; Ramlan SR; Brown CJ
J Vis Exp; 2020 May; (159):. PubMed ID: 32421011
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein.
Cuesta R; Xi Q; Schneider RJ
J Virol; 2004 Jul; 78(14):7707-16. PubMed ID: 15220445
[TBL] [Abstract][Full Text] [Related]
11. RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes.
Robert F; Cencic R; Cai R; Schmeing TM; Pelletier J
Nucleic Acids Res; 2020 Sep; 48(15):8562-8575. PubMed ID: 32749456
[TBL] [Abstract][Full Text] [Related]
12. Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E.
Gross JD; Moerke NJ; von der Haar T; Lugovskoy AA; Sachs AB; McCarthy JE; Wagner G
Cell; 2003 Dec; 115(6):739-50. PubMed ID: 14675538
[TBL] [Abstract][Full Text] [Related]
13. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5'-Cap by domains of eIF4G.
von Der Haar T; Ball PD; McCarthy JE
J Biol Chem; 2000 Sep; 275(39):30551-5. PubMed ID: 10887196
[TBL] [Abstract][Full Text] [Related]
15. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
[TBL] [Abstract][Full Text] [Related]
16. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G.
Ali IK; McKendrick L; Morley SJ; Jackson RJ
J Virol; 2001 Sep; 75(17):7854-63. PubMed ID: 11483729
[TBL] [Abstract][Full Text] [Related]
17. The nematode eukaryotic translation initiation factor 4E/G complex works with a trans-spliced leader stem-loop to enable efficient translation of trimethylguanosine-capped RNAs.
Wallace A; Filbin ME; Veo B; McFarland C; Stepinski J; Jankowska-Anyszka M; Darzynkiewicz E; Davis RE
Mol Cell Biol; 2010 Apr; 30(8):1958-70. PubMed ID: 20154140
[TBL] [Abstract][Full Text] [Related]
18. Requirement of RNA binding of mammalian eukaryotic translation initiation factor 4GI (eIF4GI) for efficient interaction of eIF4E with the mRNA cap.
Yanagiya A; Svitkin YV; Shibata S; Mikami S; Imataka H; Sonenberg N
Mol Cell Biol; 2009 Mar; 29(6):1661-9. PubMed ID: 19114555
[TBL] [Abstract][Full Text] [Related]
19. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
Fan S; Li Y; Yue P; Khuri FR; Sun SY
Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
[TBL] [Abstract][Full Text] [Related]
20. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
